In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review We are, without a doubt, at a tipping point with the current state of pharmacy practice. Drug shortages, staffing shortages,
OVERLAND PARK, Kan. — Pharmacy First, a leading Pharmacy Services Administrative Organization (PSAO) supporting a network of independent pharmacies, has partnered with Medversant Technologies, LLC to collaboratively bring together a robust credentialing, compliance and monitoring program for Pharmacy First members. Medversant’s management platform is a comprehensive verification solution for CFR 455. It automatically monitors OIG
SCOTTSDALE, Ariz. — Lee Ann Stember, president of the National Council for Prescription Drug Programs (NCPDP), has been named as one of the “Most Powerful Women in Healthcare IT” by health care journal Health Data Management. “This is a tremendous honor,” Stember said in a statement. “Just last week we held NCPDP’s 40th Anniversary Conference
SCOTTSDALE, Ariz. — McNeil Consumer Healthcare has joined the National Council for Prescription Drug Programs (NCPDP) Elite Partner Program. NCPDP said Wednesday that the Elite Partner Program establishes the highest level of sustained support for the council’s efforts to advance patient safety and interoperability. Elite Partners make a three-year commitment. The program provides critical support
SCOTTSDALE, Ariz. — AmerisourceBergen Corp. has joined the National Council for Prescription Drug Programs’ Elite Partner Program. NCPDP said Tuesday that as an Elite Partner, AmerisourceBergen will provide critical support of the valuable standards development and other work of NCPDP, including its continuing evolution as a forum for health care business, patient safety issues, education, new product development and the
The National Council for Prescription Drug Programs took part in the meeting that may result in the rollout of the nation’s first biosimilar medication. John Klimek, senior vice president for standards and industry information technology at NCPDP, addressed the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) and Oncologic Drugs Advisory Committee (ODAC)
